Literature DB >> 12487813

Processing of the HTLV-II envelope precursor glycoprotein gp63 by furin is essential for cell fusion activity.

Hideki Hasegawa1, Masashi Tatsumi, Kiyoko Ogawa-Goto, Hidehiro Takahashi, Asato Kojima, Takuya Iwasaki, Takeshi Kurata, Tetsutaro Sata, Toshiyuji Takeuchi, Noreen Sheehy, Hirofumi Sawa, Kazuo Nagashima, William W Hall.   

Abstract

To investigate the relationship between the fusogenic properties of HTLV-II and the processing of the envelope precursor glycoprotein gp63, recombinant cowpox virus expressing this protein was used to infect a range of cell lines derived from different species. Syncytium formation and gp63 processing were observed in all cells with the exception of LoVo cells, which are known to have a dysfunctional form of the endoprotease, furin. Furin has been shown to be necessary for the processing of a number of viral envelope glycoproteins, and gp63 contains a consensus sequence (305)Arg-Arg-Arg-Arg, which is a furin substrate motif. Pulse-chase studies demonstrated gp63 processing in Vero but not in LoVo cells. In addition it could be shown that expression of recombinant furin restored the processing of gp63 to gp46 in LoVo cells, and this resulted in syncytium formation. Our findings suggest that furin plays a pivotal role in cleavage of the HTLV-II envelope gp63, which in turn is a prerequisite for the fusogenic properties of the virus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12487813     DOI: 10.1089/088922202320886299

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  2 in total

1.  Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin.

Authors:  Matthew W Parker; Lance M Hellman; Ping Xu; Michael G Fried; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

2.  Host Manipulation Mechanisms of SARS-CoV-2.

Authors:  Steven E Massey
Journal:  Acta Biotheor       Date:  2021-12-13       Impact factor: 1.185

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.